• Current Issue
    Issue Dated Sep 7 2015
    slide down
  • Current Issue
    Issue Dated Sep 7 2015
    slide down
Israel-based Teva has offered to acquire US-based Mylan for $40 billion to create a generic drug powerhouse to compete with rivals such as Sun Pharmaceutical Industries from India.

Follow

our people

your favourite columnists now easily reachable

slide down

 

teva

List
Grid

Tag quick tab

Facebook Comments Box